Victory Capital Management
LYEL icon

Victory Capital Management’s Lyell Immunopharma LYEL Stock Holding History

Victory Capital Management’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-757
Closed -$8.15K – 2521
2025
Q1 		$8.15K Sell
757
-135
-15% -$1.65K ﹤0.01% 2461
2024
Q4 		$11.4K Buy
892
+172
+24% +$3.41K ﹤0.01% 2467
2024
Q3 		$19.9K Sell
720
-45
-6% -$1.32K ﹤0.01% 2445
2024
Q2 		$22.2K Sell
765
-2
-0.3% -$95 ﹤0.01% 2424
2024
Q1 		$34.2K Sell
767
-64
-8% -$2.74K ﹤0.01% 2407
2023
Q4 		$32.2K Buy
831
+169
+26% +$6.09K ﹤0.01% 2476
2023
Q3 		$19.5K Buy
662
+7
+1% +$332 ﹤0.01% 2448
2023
Q2 		$41.7K Sell
655
-15
-2% -$830 ﹤0.01% 2403
2023
Q1 		$31.6K Buy
+670
New +$35.8K ﹤0.01% 2478
2022
Q3 		– Sell
-1,158
Closed -$151K – 2739
2022
Q2 		$151K Sell
1,158
-8,473
-88% -$866K ﹤0.01% 2403
2022
Q1 		$975K Sell
9,631
-688
-7% -$83.4K ﹤0.01% 1826
2021
Q4 		$1.6M Sell
10,319
-175
-2% -$39K ﹤0.01% 1638
2021
Q3 		$3.11M Buy
10,494
+852
+9% +$255K ﹤0.01% 1456
2021
Q2 		$3.13M Buy
+9,642
New +$3.16M ﹤0.01% 1498

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Victory Capital Management's LYEL Position: Q2 2025 in Review

Victory Capital Management sold out of Lyell Immunopharma (LYEL) in Q2 2025, closing a stake of 757 shares — an estimated $8.15K sold.

Victory Capital Management first reported a position in LYEL in Q2 2021 and held it in 14 quarters. The position peaked at $3.13M in Q2 2021. 69 funds tracked by Wall St. Rank hold LYEL as of Q2 2025.

  • Victory Capital Management reported no remaining Lyell Immunopharma position as of Q2 2025 after selling out during the quarter.
  • Victory Capital Management sold 757 Lyell Immunopharma shares in Q2 2025, an estimated $8.15K.
  • Victory Capital Management first reported a position in Lyell Immunopharma in Q2 2021 and held it in 14 quarters.
  • Victory Capital Management's Lyell Immunopharma position peaked at $3.13M in Q2 2021.
  • 69 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2025.

Based on Victory Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.